Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation

10.1097/01.tp.0000166921.14670.33

Saved in:

Bibliographic Details
Main Authors:	Vathsala, A, Ona, ET, Tan, SY, Suresh, S, Lou, HX, Casasola, CBC, Wong, HC, Machin, D, Chiang, GSC, Danguilan, RA, Calne, R
Other Authors:	SURGERY
Format:	Article
Published:	Ovid Technologies (Wolters Kluwer Health) 2022
Subjects:	Adolescent Adult Aged Alemtuzumab Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Neoplasm Cyclosporine Female Graft Rejection Humans Immunotherapy Kidney Kidney Function Tests Kidney Transplantation Male Middle Aged Time Factors
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/229456
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-229456
record_format	dspace
spelling	sg-nus-scholar.10635-2294562024-04-25T01:19:52Z Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation Vathsala, A Ona, ET Tan, SY Suresh, S Lou, HX Casasola, CBC Wong, HC Machin, D Chiang, GSC Danguilan, RA Calne, R SURGERY MEDICINE Adolescent Adult Aged Alemtuzumab Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Neoplasm Cyclosporine Female Graft Rejection Humans Immunotherapy Kidney Kidney Function Tests Kidney Transplantation Male Middle Aged Time Factors 10.1097/01.tp.0000166921.14670.33 Transplantation 80 6 765-774 2022-07-29T07:14:09Z 2022-07-29T07:14:09Z 2005-09-27 2022-07-23T14:20:22Z Article Vathsala, A, Ona, ET, Tan, SY, Suresh, S, Lou, HX, Casasola, CBC, Wong, HC, Machin, D, Chiang, GSC, Danguilan, RA, Calne, R (2005-09-27). Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation. Transplantation 80 (6) : 765-774. ScholarBank@NUS Repository. https://doi.org/10.1097/01.tp.0000166921.14670.33 0041-1337 1534-6080 https://scholarbank.nus.edu.sg/handle/10635/229456 Ovid Technologies (Wolters Kluwer Health) Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	Adolescent Adult Aged Alemtuzumab Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Neoplasm Cyclosporine Female Graft Rejection Humans Immunotherapy Kidney Kidney Function Tests Kidney Transplantation Male Middle Aged Time Factors
spellingShingle	Adolescent Adult Aged Alemtuzumab Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antibodies, Neoplasm Cyclosporine Female Graft Rejection Humans Immunotherapy Kidney Kidney Function Tests Kidney Transplantation Male Middle Aged Time Factors Vathsala, A Ona, ET Tan, SY Suresh, S Lou, HX Casasola, CBC Wong, HC Machin, D Chiang, GSC Danguilan, RA Calne, R Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
description	10.1097/01.tp.0000166921.14670.33
author2	SURGERY
author_facet	SURGERY Vathsala, A Ona, ET Tan, SY Suresh, S Lou, HX Casasola, CBC Wong, HC Machin, D Chiang, GSC Danguilan, RA Calne, R
format	Article
author	Vathsala, A Ona, ET Tan, SY Suresh, S Lou, HX Casasola, CBC Wong, HC Machin, D Chiang, GSC Danguilan, RA Calne, R
author_sort	Vathsala, A
title	Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
title_short	Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
title_full	Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
title_fullStr	Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
title_full_unstemmed	Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
title_sort	randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation
publisher	Ovid Technologies (Wolters Kluwer Health)
publishDate	2022
url	https://scholarbank.nus.edu.sg/handle/10635/229456
_version_	1800915534588411904

Randomized trial of alemtuzumab for prevention of graft rejection and preservation of renal function after kidney transplantation

Similar Items